THE STUDY OF STABILITY AND SHELF LIFE OF “TRITERRIS 0.25” CAPSULE

Gulnoza K. Umarova Assistant, Candidate of pharmaceutical sciences, Tashkent Pharmaceutical Institute, st. Oybek 45, Tashkent, Uzbekistan. Email: dr.xayrullo@gmail.com.
K.A. Uboydullaev Associate professor, Tashkent Pharmaceutical Institute, st. Oybek 45, Tashkent, Uzbekistan. Email: dr.xayrullo@gmail.com.
Khusan M. Komilov Professor, Tashkent Pharmaceutical Institute, st. Oybek 45, Tashkent, Uzbekistan. Email: dr.xayrullo@gmail.com.

Abstract

Stability is an indicator of the quality of medicines. During storage under the proposed conditions for a certain time, the drug must meet the requirements of the regulatory document in all respects. A change in the description, solubility, authenticity or quantitative content of the pharmaceutical active ingredient of a medicinal product confirms the origin of molecular changes, as a result of which the quality of the product is lost.

Keywords:

capsules, stability, aging method, furostanol saponins, tannins, rutin, asparagine.


Full Text:

PDF


References


1. G.Umarov, V.Khaydarov, Kh.Komilov, Development of the composition and technology of encapsulated dosage form from dry extract of creeping anchors, Pharmaceutical journal,2017, № 1 2. G. Umarova, Kh. M. Komilov, Standardization of capsules of "Triterris", Pharmaceutical journal, 2017, № 4 3. A.Meshkovsky, WHO’s recommendations for studying the stability of pharmaceutical products, Pharmacy No. 6/95, p-12-15. 4. Garrett E.A. Prodition of stability of drugs and pharmaceutical preparationis ,J.Pharm.Sci. 1962,51, C-8 5. Belenky M. L. Elements of quantitative assessment of pharmacological effect / M. L. Belenky – L.: State Publishing House of Medical Literature, 1963-152 p. 6. Stepanov Yu. M., Filippova A. Yu., Kononov I. N. Medicinal liver lesions: pathogenesis, classification, diagnosis, treatment / / http: journal. issep. rssi..ru. – 2007 7. Puzirev V.P. Pharmacogenetic // Media gynecology.- 2003.-Jul. – P. 21-46. 8. Bott RF., Oliveira WP. Storage conditions for stability testing of pharmaceuticals in hot and humid regions. Drug Dev.and Indus. Pharm, 2007; 33: 393-401. 9. Kommanaboyina B., Rhodes CT. Trends in stability Testing, with Emphasis on Stability During Distribution and Storage. Drug Dev.Ind. Pharm, 1999; 25 8 57-867. 10. ICH Q6A: “Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. 11. Y Sumie and Valentino J. Stella. World Health Organisation, WHO Guidelines on Stability Testing, WHO Drug information. 12. Quinlan M, Stroup W, Christopher D, Schwenke J. On the distribution of batch shelf lives. (Accepted for publication in J Biopharm Stat. 2011). 13. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Q1E evaluation of stability data; 2004. 14. Stroup W, Quinlan, M. Alternative shelf life estimation methodologies. In JSM Proceedings, Biopharmaceutical Section. Alexandria, VA: American Statistical Association. 2010;2056–x 2066. 15. International Organization for Standardization. ISO 3951:1989. Sampling procedures and charts for inspection by variables for percent nonconforming. http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=9602. Accessed 18 June 2012. 16. Tembhare E, Gupta K.R, Umekar M.J. An Approach to Drug Stability Studies and Shelf-life Determination. Arch. Curr. Res. Int., 2019;19(1):1-20. 17. International Conference on Harmonization (ICH). Topic Q1A(R2) Stability Testing of New Drug Substances and Products. 2003. Available from: http://www.ich.org/products/guidelines/quality/quality-single/article/stability-testingof-new-drug-substances-and-products. 18. Guide to good storage practices for pharmaceuticals. In: WHO Expert 1597 Committee on Specifications for Pharmaceutical Preparations. 1598 Thirty-seventh report. Geneva, World Health Organization, 2003, 1599 Annex 9 (WHO Technical Report Series, No. 908). 19. Good distribution practices for pharmaceutical products. In: WHO 1601 Expert Committee on Specifications for Pharmaceutical 1602 Preparations. Forty-fourth report. Geneva, World Health 1603 Organization, 2010, Annex 5 (WHO Technical Report Series, No. 1604 957). 20. Cha J., Gilmor T., Lane P., Ranweiler JS. Stability studies in Handbook of modern pharmaceutical analysis. Separation Science and Technology. Elsevier (2001) 459-505.

Refbacks

  • There are currently no refbacks.